Despite its comprehensive framework, FIFRA faces challenges such as the need for updated testing methods that better predict human health risks. There is also ongoing debate about the adequacy of current safety standards, particularly regarding endocrine disruptors and other emerging contaminants. Addressing these challenges requires ongoing research and collaboration between regulatory agencies, scientists, and stakeholders.
